Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05745480 · ClinicalTrials.gov registry record

Natural Language Processing for Screening Opioid Misuse

A clinical trial of Opioid Use Disorder and Opioid Misuse, sponsored by University of Wisconsin, Madison.

Completed
Registry status
47,502
Enrollment target
1
Study location

NCT05745480: Completed study of Opioid Use Disorder and Opioid Misuse, sponsored by University of Wisconsin, Madison.

NCT05745480 is a study of Opioid Use Disorder and Opioid Misuse that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 47,502 participants, above the 4,471-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (962% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05745480, a study of Opioid Use Disorder and Opioid Misuse, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
47,502 participants
Enrollment target
1
Study location

Study Summary

This is a clinical study to implement and evaluate a hospital-wide, operational intervention for a real-time natural language processing (NLP)-driven clinical decision support (CDS) tool, called Substance Misuse Algorithm for Referral to Treatment Using Artificial Intelligence (SMART-AI). The SMART-AI CDS tool will be evaluated via implementation in the UW Health electronic health record (EHR). The CDS tool is meant for screening inpatient adults for opioid misuse as part of a best practice alert to nurses and providers for addiction consult service needs.

Primary Outcome

Percentage of inpatients who screened positive (or would have screened positive) based on the NLP CDS tool who received an addiction consult with any of the following interventions: (1) receipt of opioid use intervention or motivational interviewing (MI); (2) receipt of medication-assisted treatment (MAT); and/or (3) referral to substance use disorder treatment.

Interventions

  • OTHER Opioid Misuse Screening with an Addiction Consult Service

Study Locations (1)

Wisconsin

  • University of Wisconsin Hospital (UW Health) - Madison

Trial Details

FieldValue
Enrollment Target 47,502 participants
Start Date 2023-03-06
Est. Completion 2023-12-31
University of Wisconsin, Madison

1,039 total trials

What the finished NCT05745480 record still lists

NCT05745480 is an observational study that tracks outcomes without assigning an intervention. Its 47,502 participants enrollment target places it among the larger protocols in the corpus, above the 4,471-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (962% higher).

The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Opioid Misuse Screening with an Addiction Consult Service is the first listed.

NCT05745480 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05745480 about?

NCT05745480 is a clinical study titled "Natural Language Processing for Screening Opioid Misuse". This is a clinical study to implement and evaluate a hospital-wide, operational intervention for a real-time natural language processing (NLP)-driven clinical decision support (CDS) tool, called Substance Misuse Algorithm for Referral to Treatment Using Artificial Intelligence (SMART-AI). The SMART-...

What is the current status of trial NCT05745480?

This trial is currently completed. The enrollment target is 47,502 participants. The study started on 2023-03-06. Estimated completion is 2023-12-31.

What conditions does trial NCT05745480 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Opioid Misuse.

What interventions are being tested in trial NCT05745480?

The interventions under investigation include: Opioid Misuse Screening with an Addiction Consult Service (OTHER).

Who is sponsoring clinical trial NCT05745480?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05745480 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05745480's enrollment target sits among peer trials

47,502 2nd of 257 the highest of 257 other Opioid Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03977402 · 47,500 participants

    Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

  • NCT06655974 · 48,000 participants · NA

    Predictive Modeling for Social Needs in Emergency Department Settings

  • NCT06597968 · 45,991 participants

    Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool

  • NCT06824350 · 45,450 participants · NA

    Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05745480, the US trial registry maintained by the National Library of Medicine. NCT05745480 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.